Proposed Data Collections Submitted for Public Comment and Recommendations, 5086-5087 [2010-2059]
Download as PDF
<![CDATA[
5086
Federal Register / Vol. 75, No. 20 / Monday, February 1, 2010 / Notices
EXHIBIT 3—ESTIMATED TOTAL AND ANNUALIZED COST—Continued
Cost component
Total cost
Total ..........................................................................................................................................................
Request for Comments
In accordance with the above-cited
Paperwork Reduction Act legislation,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) Whether the
proposed collection of information is
necessary for the proper performance of
AHRQ health care research, quality
improvement and information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’ s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: January 25, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010–1894 Filed 1–29–10; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–10–0745]
jlentini on DSKJ8SOYB1PROD with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam Daneshvar,
VerDate Nov<24>2008
18:35 Jan 29, 2010
Jkt 220001
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Colorectal Cancer Screening Program
(OMB Number 0920–0745, exp. 7/31/
2010)—Revision—Division of Cancer
Prevention and Control (DCPC),
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Colorectal Cancer (CRC) is the second
leading cause of cancer-related deaths in
the United States, following lung
cancer. Based on scientific evidence
which indicates that regular screening is
effective in reducing CRC incidence and
mortality, regular CRC screening is now
recommended for average-risk persons.
Screening tests that are recommended
by the United States Preventive Services
Task Force, and that may be used alone
or in combination, include fecal occult
blood testing (FOBT), fecal
immunochemical testing (FIT), flexible
sigmoidoscopy, colonoscopy, and/or
double-contrast barium enema (DCBE).
In 2005, CDC established a three-year
demonstration program, subsequently
extended to four years, to screen lowincome individuals 50 years of age and
older who have no health insurance or
inadequate health insurance for CRC.
The five demonstration sites report
information to CDC including deidentified, patient-level demographic,
screening, diagnostic, treatment,
outcome and cost reimbursement data
(OMB No. 0920–0745, exp. 7/31/2010).
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
5,703
Annualized cost
5,703
The information is being used to assess
the feasibility and cost effectiveness of
a publicly funded screening program
and describe key outcomes, and has
been critical in guiding the expansion of
the program.
CDC will request OMB approval to
continue the information collection for
three years, with changes. First, the
number of funded sites will increase
from 5 to 26, and the term
‘‘Demonstration’’ will be deleted from
the title of the program. Second, there
will be a reduction in the burden per
respondent associated with the
collection of clinical information.
Reporting forms for medical
complications and medically ineligible
clients will be discontinued, and
reporting forms for colorectal cancer
clinical data elements (CCDE) will be
streamlined. Data elements that were
underused in analysis of the
demonstration program data, or difficult
to standardize across programs, will be
removed, and the level of detail
collected from endoscopy and pathology
reports will be reduced. As a result, the
reporting burden per CCDE form will be
similar regardless of primary test
provided. Third, the collection of
patient-level reimbursement cost data
will be discontinued and will be
replaced by the collection of programlevel activity-based cost data. The
revised information collection will
utilize a Cost Assessment Tool (CAT)
currently in use by another CDC-funded
cancer program (OMB No. 0920–0812,
exp. 6/30/2012). The information to be
collected through the CAT will allow
CDC to compare activity-based costs
across multiple sites and programs, and
will provide a more effective means of
monitoring and improving the
performance and cost-effectiveness of
the CRC screening program.
The goals of the expanded CRC
screening program are to increase
population-based screening and to
reduce health disparities in CRC
screening, incidence and mortality. The
program will continue to provide
services to low-income individuals age
50 and older with inadequate or no
health insurance. Each site will screen
an estimated 375 patients per year (186
semiannually). The increase in the
number of funded sites and the
proposed changes will result in an
E:\FR\FM\01FEN1.SGM
01FEN1
5087
Federal Register / Vol. 75, No. 20 / Monday, February 1, 2010 / Notices
overall increase in burden to
respondents.
CCDE information will be transmitted
to CDC electronically twice per year.
Information collected through the Cost
Assessment Tool will be transmitted
electronically to CDC once per year.
Participation is required for all sites
funded through the CRC screening
program. There are no costs to
respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondents
Form type
Colorectal Cancer Screening Programs.
Clinical Data Elements .....................
26
375
15/60
2,438
Cost Assessment Tool .....................
26
1
22
572
...........................................................
........................
........................
........................
3,010
Total ...........................................
Dated: January 26, 2010.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2010–2059 Filed 1–29–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–10–10BG]
jlentini on DSKJ8SOYB1PROD with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
VerDate Nov<24>2008
18:35 Jan 29, 2010
Jkt 220001
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Voluntary Environmental
Assessment Information System
(NVEAIS)—New—National Center for
Environmental Health (NCEH), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The CDC is requesting OMB approval
for a National Voluntary Environmental
Assessment Information System to
collect data from food- and waterborne
illness outbreak environmental
assessments routinely conducted by
local, State, territorial, or tribal food and
water safety programs during outbreak
investigations. Environmental
assessment data are not currently
collected at the national level. The data
reported through this information
system will provide timely data on the
causes of outbreaks, including
environmental factors associated with
outbreaks, and are essential to
environmental public health regulators’
efforts to respond more effectively to
outbreaks and prevent future, similar
outbreaks. This information system is
specifically designed to link to CDC’s
existing disease outbreak surveillance
system (National Outbreak Reporting
System).
The information system was
developed by the Environmental Health
Specialists Network (EHS–Net), a
collaborative project of CDC, the U.S.
Food and Drug Administration (FDA),
the U.S. Department of Agriculture
(USDA), and nine states (California,
Connecticut, Georgia, Iowa, New York,
Minnesota, Oregon, Rhode Island, and
Tennessee). The network consists of
environmental health specialists (EHSs),
epidemiologists, and laboratorians. The
EHS–Net has developed a standardized
protocol for identifying, reporting, and
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
analyzing data relevant to food- and
waterborne illness outbreak
environmental assessments.
The information to be reported to
NVEAIS will be obtained from
environmental assessments routinely
conducted by state, local, tribal and
territorial food and water safety program
officials in response to food- and
waterborne illness outbreaks. While
conducting environmental assessments
during outbreak investigations is routine
for food and water safety program
officials, reporting information from the
environmental assessments to CDC is
not. Thus, state, local, tribal, and
territorial food and water safety program
officials are the respondents for this
data collection. However, participation
in the system is voluntary.
There are approximately 3,000 public
health departments (where food and
water safety programs are typically
located) in the United States. Many of
these departments have separate food
and water safety programs. If a public
health department chooses to
participate in NVEAIS, there will likely
be two respondents from that
department—one person responsible for
reporting foodborne outbreak
environmental assessment data to
NVEAIS and one person responsible for
reporting waterborne outbreak
environmental assessment data to
NVEAIS. Thus, although it is not
possible to determine how many
departments will choose to participate,
as NVEAIS is voluntary, the maximum
potential number of respondents is
approximately 6,000 (one for each food
safety program and one for each water
safety program in each public health
department).
It is not possible to determine exactly
how many outbreaks will occur in the
future, nor where they will occur.
However, we can estimate, based on
existing data, that a maximum of 1,600
illness outbreaks (1,100 foodborne and
500 waterborne) will occur annually.
E:\FR\FM\01FEN1.SGM
01FEN1
]]>Agencies
[Federal Register Volume 75, Number 20 (Monday, February 1, 2010)]
[Notices]
[Pages 5086-5087]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-2059]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-10-0745]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Maryam Daneshvar, CDC Acting Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Colorectal Cancer Screening Program (OMB Number 0920-0745, exp. 7/
31/2010)--Revision--Division of Cancer Prevention and Control (DCPC),
National Center for Chronic Disease Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Colorectal Cancer (CRC) is the second leading cause of cancer-
related deaths in the United States, following lung cancer. Based on
scientific evidence which indicates that regular screening is effective
in reducing CRC incidence and mortality, regular CRC screening is now
recommended for average-risk persons. Screening tests that are
recommended by the United States Preventive Services Task Force, and
that may be used alone or in combination, include fecal occult blood
testing (FOBT), fecal immunochemical testing (FIT), flexible
sigmoidoscopy, colonoscopy, and/or double-contrast barium enema (DCBE).
In 2005, CDC established a three-year demonstration program,
subsequently extended to four years, to screen low-income individuals
50 years of age and older who have no health insurance or inadequate
health insurance for CRC. The five demonstration sites report
information to CDC including de-identified, patient-level demographic,
screening, diagnostic, treatment, outcome and cost reimbursement data
(OMB No. 0920-0745, exp. 7/31/2010). The information is being used to
assess the feasibility and cost effectiveness of a publicly funded
screening program and describe key outcomes, and has been critical in
guiding the expansion of the program.
CDC will request OMB approval to continue the information
collection for three years, with changes. First, the number of funded
sites will increase from 5 to 26, and the term ``Demonstration'' will
be deleted from the title of the program. Second, there will be a
reduction in the burden per respondent associated with the collection
of clinical information. Reporting forms for medical complications and
medically ineligible clients will be discontinued, and reporting forms
for colorectal cancer clinical data elements (CCDE) will be
streamlined. Data elements that were underused in analysis of the
demonstration program data, or difficult to standardize across
programs, will be removed, and the level of detail collected from
endoscopy and pathology reports will be reduced. As a result, the
reporting burden per CCDE form will be similar regardless of primary
test provided. Third, the collection of patient-level reimbursement
cost data will be discontinued and will be replaced by the collection
of program-level activity-based cost data. The revised information
collection will utilize a Cost Assessment Tool (CAT) currently in use
by another CDC-funded cancer program (OMB No. 0920-0812, exp. 6/30/
2012). The information to be collected through the CAT will allow CDC
to compare activity-based costs across multiple sites and programs, and
will provide a more effective means of monitoring and improving the
performance and cost-effectiveness of the CRC screening program.
The goals of the expanded CRC screening program are to increase
population-based screening and to reduce health disparities in CRC
screening, incidence and mortality. The program will continue to
provide services to low-income individuals age 50 and older with
inadequate or no health insurance. Each site will screen an estimated
375 patients per year (186 semiannually). The increase in the number of
funded sites and the proposed changes will result in an
[[Page 5087]]
overall increase in burden to respondents.
CCDE information will be transmitted to CDC electronically twice
per year. Information collected through the Cost Assessment Tool will
be transmitted electronically to CDC once per year. Participation is
required for all sites funded through the CRC screening program. There
are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form type respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Colorectal Cancer Screening Clinical Data 26 375 15/60 2,438
Programs. Elements.
Cost Assessment 26 1 22 572
Tool.
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 3,010
----------------------------------------------------------------------------------------------------------------
Dated: January 26, 2010.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2010-2059 Filed 1-29-10; 8:45 am]
BILLING CODE 4163-18-P
